Home/Filings/4/0001209191-18-014684
4//SEC Filing

McKenzie Kathryn B 4

Accession 0001209191-18-014684

CIK 0001077183other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 6:59 PM ET

Size

7.0 KB

Accession

0001209191-18-014684

Insider Transaction Report

Form 4
Period: 2018-02-26
McKenzie Kathryn B
Principal Accounting Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-02-26$8.03/sh+48,000$385,44048,000 total
    Exercise: $8.03From: 2019-02-26Exp: 2023-02-26Common Stock (48,000 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $9.52From: 2018-10-17Exp: 2022-10-17Common Stock (25,000 underlying)
    25,000
Footnotes (2)
  • [F1]On October 18, 2017, Ms. McKenzie was granted an option to purchase 25,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
  • [F2]On February 26, 2018, Ms. McKenzie was granted an option to purchase 48,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.

Issuer

NEOGENOMICS INC

CIK 0001077183

Entity typeother

Related Parties

1
  • filerCIK 0001720001

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:59 PM ET
Size
7.0 KB